Biotech News

Ascendis Pharma to Participate in the Jefferies London Healthcare Conference

Ascendis Pharma (ASND)Ascendis PharmaConference / presentation

COPENHAGEN, Denmark, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 17, 2026, at 11:30 a.m. Greenwich Mean Time (GMT) / 6:30 a.m.

Related news

Ascendis Pharma

TransCon Technology Ascendis Pharma applies its TransCon prodrug platform to create long-acting therapies that release an unmodified parent drug over time. Its portfolio spans endocrinology, rare growth disorders and oncology. Commercial Endocrinology Portfolio YORVIPATH is a parathyroid-hormone replacement therapy for chronic...

Recent company news

Stock data

Close
255.96 USD
Market cap
13.38B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States